IP Portfolio Assessment: 6 Proven Steps to Cut Costs

Most portfolios grow by default. Something gets filed, it issues, and from then on the renewal gets paid because nobody wants to be the person who killed a patent. That default is expensive — and it gets more expensive at every renewal window. A disciplined IP portfolio assessment replaces the default with a decision, and the decision is usually worth real money. The hard part isn’t deciding to do one. It’s building a rubric your CFO and your business units will both accept.

What an IP Portfolio Assessment Covers

An inventory tells you what you own. An assessment tells you what to do about it. The output isn’t a list of assets — it’s three lists: what you keep funding, what you let go, and what you try to make money from.

Teams typically run one for a specific trigger:

• Annual budget season, when IP spend has to be justified line by line.
• A renewal cliff, when a cohort of patents hits a fee window together.
• A transaction, where a buyer or investor is about to do this analysis for you.
• A strategy shift, when the company exits a product line and the patents around it stop mattering.

The trigger shapes the depth. A budget review can be lighter than transaction diligence — but the rubric should be the same one either way, or the results won’t be comparable year over year.

The Maintenance Fee Math That Forces the Decision

US utility patents carry maintenance fees at three points: 3.5, 7.5, and 11.5 years after issue, under 35 U.S.C. § 41(b) and 37 CFR 1.362. The fees escalate sharply, which is precisely why they function as natural decision gates.

Under the USPTO fee schedule effective January 19, 2025, undiscounted entity amounts are $2,150 at 3.5 years, $4,040 at 7.5 years, and $8,280 at 11.5 years. Small entities pay 60% less and micro entities 80% less — so the same three payments run $860 / $1,616 / $3,312 for a small entity, and $430 / $808 / $1,656 for a micro entity.

Two consequences follow, and both matter more than the individual numbers:

• The back half dominates. Well over half the lifetime US maintenance cost of a patent sits in that final payment. A patent you’re unsure about at 7.5 years is a patent you should be actively deciding about, not renewing reflexively.
• Entity status is money. Claiming small or micro entity status when you no longer qualify creates real exposure, and failing to claim it when you do qualify wastes 60–80% of every fee. Verify status per asset, not per company.

Miss a window and there’s a six-month grace period with a surcharge — $540 undiscounted, $216 small, $108 micro. Design patents, worth noting, carry no US maintenance fees at all, so they don’t belong in this part of the analysis. Current figures are always on the USPTO fee schedule, and foreign annuities follow entirely separate rules that usually dwarf the US numbers.

A Scoring Rubric You Can Actually Defend

Vendor content on this topic tends to list evaluation factors and stop there. Factors without weights just relocate the argument. Score each asset 1–5 on five criteria, weight them, and total:

1. Business alignment (weight 3). Does this read on a product you currently sell or plan to? The single strongest predictor of whether an asset is worth keeping.
2. Claim strength and scope (weight 3). Would the claims actually stop a competitor, or are they so narrow that designing around is trivial?
3. Competitive relevance (weight 2). Is anyone else operating in this space? A patent nobody would ever infringe has little defensive value.
4. Licensing or sale potential (weight 2). Is there a market for it outside your own use?
5. Cost to maintain (weight 1, inverted). Multi-jurisdiction families with heavy annuities need a higher bar than a single US patent.

Agree the weights before anyone sees a score. Doing it in the other order turns the exercise into advocacy. And record the reasoning in one sentence per asset — a year later, that sentence is the only thing that makes the decision reviewable.

Keep, Prune, or Monetize: The Three Buckets

Scores sort assets into buckets, but the buckets need thresholds set in advance and a genuine escape hatch.

• Keep. High business alignment or high claim strength. Fund without further debate and revisit at the next fee window.
• Monetize. Weak alignment to your business, but real strength or relevance to someone else’s. Sale, license, or contribution to a pool — and note that this bucket has a shelf life, since an asset gets harder to sell as it ages toward the 11.5-year payment.
• Prune. Low on everything. Stop paying and let it lapse.
• Hold for review. The escape hatch. Genuine uncertainty, usually because a product decision is pending. Cap this bucket deliberately, or everything lands in it.

One caution worth stating plainly: pruning is not purely a cost exercise. A patent that looks dead weight against today’s products can matter enormously if you’re later accused of infringement and need something to assert back. Weigh defensive value before you cut, particularly in litigious sectors. Our guide to patent portfolio analysis goes deeper on reading the competitive landscape around your assets.

What Actually Happens When You Let a Patent Lapse

This is the part that makes people hesitate, and it’s usually left out of the guides that recommend pruning. Here’s the mechanism.

Miss a maintenance fee and the patent expires at the end of the grace period. The invention passes into the public domain — anyone can practice it, including the competitors you were worried about. That’s the point of pruning, but it should be a decision made with open eyes.

Revival is possible but not casual. Under 37 CFR 1.378, a patent that expired for non-payment can be reinstated by petition if the delay was unintentional, accompanied by the outstanding fee and a petition fee. Two things follow:

• A deliberate decision not to pay isn’t unintentional. If you pruned on purpose and later change your mind, that route is not designed for you.
• Intervening rights can attach. Third parties who began practicing the invention during the lapse may retain protection even after reinstatement, which can hollow out the patent’s practical value.

So treat pruning as one-way. Which is an argument for the rubric, not against pruning: reversible decisions can be sloppy, irreversible ones need a written rationale.

Who Should Be in the Room — and When to Run It

An assessment run entirely inside the legal department produces defensible legal scores and poor business scores. IP counsel can judge claim strength; they usually can’t tell you which product line gets discontinued next year.

• IP counsel — claim scope, validity concerns, family structure.
• Product or engineering leads — whether the asset reads on anything real, and whether it still will in two years.
• Finance — the spend forecast and the entity status question.
• An outside searcher or analyst — competitive relevance and licensing potential, where an internal team’s view is naturally inward-looking.

On timing: run the full assessment annually, ahead of budget, and screen the specific cohort hitting a fee window about six months before payment is due. Six months is enough to run a sale process if something lands in the monetize bucket; six weeks is not. If you’re also standing up systems to track all this, the reconciliation work pairs naturally with choosing an IP management system, and annuity and renewal management covers the payment mechanics.

This article is general information, not legal advice; consult a qualified attorney for your situation.

How PerspireIP Can Help

The scoring inputs most teams struggle with — competitive relevance, claim strength against real prior art, and whether anyone would actually license an asset — are search and analysis problems. That’s our work. If you have a renewal cohort coming up or a budget review to defend, talk to our team and we’ll help you build the evidence behind each decision.

Frequently Asked Questions